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Newborn small for gestational age
A B S T R A C T
Objective: To investigate the association between headache, namely migraine and tension-type
headache, and adverse pregnancy outcome.
Study design: Prospective cohort study conducted in three tertiary care centres in Italy: 376 pregnant
women suffering from headache and 326 non-headache pregnant women as controls were recruited. The
diagnosis of headache was made at the beginning of pregnancy, according to the criteria of the
International Classiﬁcation of Headache Disorders (ICHD-II). Women were followed up until delivery, and
gestational age at delivery, mode of delivery, indications for operative delivery or caesarean section, birth
weight, and centile of neonatal weight at birth were carefully recorded. Main outcome measures of the
study were: preterm delivery, newborns small for gestational age, and foetal losses. Odds ratios and 95%
conﬁdence intervals were calculated.
Results: The incidence of preterm delivery (Adj OR, 95% CI 2.74, 1.27–5.91) was signiﬁcantly higher in
women suffering from headache than in controls. There was no statistically signiﬁcant difference in small
for gestational age newborns between the groups. Fewer women in the headache group had preterm
elective caesarean section or induction of labour, than did controls, indicating a higher chance of
spontaneous preterm delivery. Multivariate analysis showed that the association between headache,
either migraine or tension-type, and adverse perinatal outcomes was statistically signiﬁcant regardless of
pre-eclampsia.
Conclusions: Women with headache should be considered at risk for adverse perinatal outcomes and
should, therefore, be included in a high-risk pregnancy protocol of care throughout pregnancy.
 2012 Elsevier Ireland Ltd. All rights reserved.
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Headache is one of the most frequent reasons for referral to a
neurology outpatient department [1]. Most headache types have a
female predominance and a peak incidence age in the second and
third decades of life [2,3]. This age range corresponds to the
childbearing years for women, thus the association of headache
and pregnancy is quite frequent. Data are available as to the effect
of pregnancy on headache and in particular on migraine, which has
been reported to improve during pregnancy in a high percentage of
patients [4–7]. The improvement of tension-type headache (TTH)
is less evident, with some studies even reporting opposite results
[6,8,9].* Corresponding author at: Via Ventimiglia 3, 10126 Torino, Italy.
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doi:10.1016/j.ejogrb.2011.12.030To date, few studies have dealt with the impact of headache on
pregnancy outcome. Although the mechanisms are not yet fully
understood, there seems to be an association between migraine
and the risk of pre-eclampsia [10,11]. In a large prospective study
[12] we recently observed that the risk of developing hypertension
in pregnancy or pre-eclampsia was signiﬁcantly higher in
migraineurs (9.1%) compared to non-migraineurs (3.1%) (OR
2.85, 95% CI 1.40–5.81). Women with migraine also showed a
tendency to increased risk of low birth weight infants [12]. Very
little information is available as to the effect of headache on
perinatal outcomes, such as preterm delivery, low birth weight
and/or intrauterine foetal growth restriction. In the limited
number of studies that have evaluated pregnancy outcomes in
migraineurs, the majority reported no increase in the incidence of
poor outcomes such as preterm labour, low birth weight and/or
congenital anomalies [8,11]. A recent study suggests that patients
with migraine were at higher risk of pre-eclampsia, preterm birth
and caesarean section compared to unaffected mothers [13].
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retrospective studies and were not adjusted for pregnancy
complications or other factors with a potential negative effect
on pregnancy outcome, and this may well represent a selection
bias. Moreover, most studies have dealt with migraine and
pregnancy, whilst very few reports have been published on the
effect of TTH on perinatal outcomes.
This scarcity of data prompted us to carry out a prospective,
multicentre, cohort study in an attempt to determine whether the
presence of headache, either migraine or tension-type, may be an
independent adverse risk factor for perinatal outcome.
2. Materials and methods
Women attending antenatal booking at three maternity units in
Italy (Departments of Obstetrics and Gynaecology, University of
Torino and Modena, and the Research Centre for Reproductive
Medicine, the University of Pavia) were enrolled into a cohort
prospective study aimed at the evaluation of the incidence of pre-
eclampsia in migraineur women.
When booking, at a gestational age of 11–16 weeks, the women
were interviewed by three researchers who had previously been
trained in headache diagnosis according to the criteria of the
International Classiﬁcation of Headache Disorders (ICHD-II) [14]. A
semistructured questionnaire was also used to facilitate the
interview and collection of data. Details of the questionnaire have
been previously reported [9]. A clinical examination was made
along with an ultrasound scan, during the enrolment interview, to
conﬁrm gestational age, and the woman’s age, years of education,
family history, last menstrual date, parity, and smoking habits
were recorded. Only Caucasian women with singleton pregnancies
were included. Chronic hypertension, pre-existing diabetes and
any other systemic disorders that might have a negative effect on
pregnancy outcome were considered exclusion criteria.
The diagnosis of headache type, i.e. migraine or TTH, was based
on the ICHD-II criteria. Attacks and/or headache lacking one of the
features required to fulﬁl the criteria for migraine with or without
aura, or TTH were coded as ‘‘probable migraine’’ or ‘‘probable TTH’’.
In some cases, the diagnosis of headache type had already been
made and was therefore conﬁrmed at enrolment. All the diagnoses
were independently reviewed by a senior researcher (G.A.).
A total of 11/753 women interviewed did not meet the
inclusion criteria. Seven women chose to terminate the pregnancy
after prenatal diagnosis of chromosomal abnormalities and 33
were lost to follow-up. Consequently, data were available for 702
women who had follow-up throughout their pregnancy. Three
hundred and seventy-six were suffering from headache and 326
were not and were therefore taken as controls. Data as to the
incidence of pre-eclampsia in pregnant women suffering from
migraine in the same cohort have been previously reported [12].
The primary objective of the study was to assess whether the
pregnant women with headache had worse perinatal outcomes
than did the controls. The information on outcomes was directly
recorded at the time of delivery, or immediately afterwards,
through medical note revision. Gestational age at delivery, mode of
delivery, indications for operative delivery or caesarean section,
birth weight, and centile of weight at birth were carefully recorded.
The following primary outcomes were considered: (1) preterm
delivery, deﬁned as a birth occurring before 37 completed weeks of
gestation, and (2) newborns that were small for gestational age
(SGA), deﬁned as a newborns whose weight was below the 10th
centile for gestational age at birth in the absence of foetal
malformations, chromosomal abnormalities, recent cytomegalo-
virus infection and/or maternal substance or alcohol abuse [15].
New onset of gestational hypertension (GH) and preeclampsia
(PE) was carefully recorded. In agreement with the criteriaestablished by the American College of Obstetricians and
Gynaecologists [16], diagnosis of GH was made in the presence
of new onset hypertension (blood pressure  140 and/or 90 mmHg
in two measurements at least 6 h apart) without proteinuria after
the 20th week of gestation in a previously normotensive woman,
that resolved within 12 weeks after delivery. PE was diagnosed if
hypertension, associated with signiﬁcant proteinuria (300 mg/
24 h), occurred after 20 weeks’ gestation in a previously
normotensive and non-proteinuric woman and resolved within
12 weeks after delivery.
Details of any changes in headache patterns and drug intake,
e.g. triptans, were also collected. Headache sufferers were
instructed to take note of any headache attacks and analgesic
use in a personal diary. All data were checked at the post-partum
interview, which was done 6–12 weeks after delivery, either
directly or by telephone.
The protocol was approved by the local Ethics Committees and
written informed consent was obtained from each subject before
enrolment.
So as to perform a power analysis of the study, we considered
that the prevalence of recurrent headaches in women of
reproductive age to be around 54% [17] and that of preterm
delivery in the general population around 10% [18]. Therefore, we
calculated that our sample size had a power of 80% to detect an
odds ratio of 2.0 at the 5% level for preterm delivery between
groups. Data were downloaded in the SPSS 12.0 software
(Statistical Package for the Social Sciences, Chicago, US). Associa-
tion between headaches and perinatal outcomes was expressed as
odds ratios (OR) and 95% conﬁdence intervals (CIs) were calculated
by the logistic regression model in SPSS. The p-values were also
reported, and considered statistically signiﬁcant when <0.05. A
multivariate logistic regression analysis was carried out to provide
adjusted OR estimates so as to account for possible differences in
the distribution of potential confounding variables, with and
without headache, in particular that of gestational hypertension
and pre-eclampsia. Only those covariates that had a p-value of <0.1
at the univariate analysis were taken into consideration in the
multivariate analysis.
3. Results
Three hundred and seventy-six of the 702 women recruited into
the study were diagnosed as headache sufferers (53.5%), and the
326 that were not diagnosed made up the controls. Six headache
patients and seven controls had spontaneous miscarriages after
enrolment. There were two foetal deaths in the headache group
(one following placental abruption and one of unknown cause) and
one early neonatal death (of a severely preterm newborn). There
were one foetal death of undetermined cause and two early
neonatal deaths following severe preterm delivery in the control
group. There was no statistically signiﬁcant difference in foetal/
neonatal losses between groups.
After exclusion of subjects with foetal losses, 367 headache
patients and 316 controls delivered a viable newborn and were
then considered for statistical analysis.
Migraine was diagnosed in 264 women (38.6%), 180/264
without aura, 35 with aura, and the remaining 49 reported a
‘‘probable’’ migraine. A diagnosis of TTH was made in 103 subjects
(15.1%), with 11/103 reporting a ‘‘probable’’ TTH.
Women with or without headache did not differ in terms of age
distribution, years of education, body mass index (BMI), smoking
habit, or family history of GH/PE, whereas a family history of
hypertension was slightly but statistically signiﬁcantly more
frequent in headache women than in controls (Table 1).
The incidence of preterm delivery (<37 weeks’ gestation) was
signiﬁcantly higher in patients suffering from headache than in
Table 1





OR (95% CI) p
n (%) n (%)
Age (years)
25 24 (7.6) 24 (6.5) Reference 0.40
26–34 235 (74.4) 262 (71.4) 1.12 (0.62–2.02)
35 57 (18.0) 81 (22.1) 1.42 (0.74–2.75)
Education (years)
<8 75 (23.7) 81 (22.1) Reference 0.84
9–13 167 (52.9) 195 (53.1) 1.08 (0.74–1.58)
>13 74 (23.4) 91 (24.8) 1.14 (0.73–1.77)
BMI
20–24.9 145 (45.9) 171 (46.6) Reference 0.48
<20 68 (21.5) 86 (23.4) 1.07 (0.73–1.58)
25–29.9 43 (13.6) 56 (15.3) 1.10 (0.70–1.74)
30 60 (19.0) 54 (14.7) 0.76 (0.50–1.17)
Parity
Nulliparous 184 (58.2) 210 (57.2) Reference 0.92
Parous 132 (41.8) 157 (42.8) 0.99 (0.73–1.34)
Family history of GH/PE
No 268 (84.8) 324 (88.3) Reference 0.36
Yes 10 (3.2) 11 (3.0) 0.91 (0.38–1.15)
Not known 38 (12.0) 32 (8.7) 0.70 (0.42–1.15)
Family history of hypertension
No 170 (53.8) 166 (45.2) Reference 0.03
Yes 111 (35.1) 165 (45.0) 1.52 (1.10–2.10)
Not known 35 (11.1) 36 (9.8) 1.11 (0.63–1.76)
Smoking habit
No 234 (74.1) 258 (70.3) Reference 0.27
Yes 82 (25.9) 109 (29.7) 1.21 (0.86–1.69)
BMI, body mass index.
GH, gestational hypertension.
PE, preeclampsia.
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completed weeks of gestation in the headache group and 6/367
(1.6%) weighed less than 2000 g. The incidence of preterm rupture
of the membranes was similar for both groups. Amongst women
who delivered preterm, 87.5% of the non-headache group had
elective caesarean section or induction of labour. Amongst
headache subjects, a lower proportion of subjects (77.7%)
underwent preterm elective caesarean section or induction of
labour, indicating a higher chance of spontaneous preterm
delivery. The difference, however, was not statistically signiﬁcant.
The indications for elective preterm delivery were similar between
the groups. There was no difference between the groups in the
prevalence of prior preterm delivery. In this regard, it is possible
that the higher proportion of nulliparae and the very high rate of
indicated preterm delivery in both groups can mask the effect of
prior preterm delivery on the risk of recurrence in the index
pregnancy. There was a higher, although not signiﬁcant, incidence
of caesarean sections and vaginal assisted deliveries in the
headache group than in controls (37.1% vs 33.5%); these ratesTable 2





n (%) n (%)
Preterm delivery (<37 weeks)
No 307 (972) 339 (92.4) 
Yes 9 (2.8) 28 (7.6) 
SGA (<10th centile)
No 304 (96.2) 353 (96.2) 
Yes 12 (3.8) 14 (3.8) 
SGA, small for gestational age.
a Adjusted for family history of hypertension and for occurrence of GH/PE.are similar to the average rate of caesarean section in our
departments for 2010 (34%).
A separate analysis was performed for the two subgroups, as the
pathophysiological aspects of migraine and TTH differ (Table 3).
The incidence of preterm delivery was higher in patients suffering
from migraine than in controls, as was the case in the whole group
of headache patients. In patients with TTH we observed a
signiﬁcantly higher incidence of preterm delivery together with
a high incidence of small for gestational age newborns which,
however, did not reach the statistical signiﬁcance.
The analysis performed according to subtypes of migraine (with
or without aura and ‘‘probable’’ migraine) and of TTH (pure or
‘‘probable’’ TTH) conﬁrmed the results and revealed no statistically
signiﬁcant differences amongst headache subtypes in terms of
perinatal outcome.
The incidence of GH/PE was signiﬁcantly higher in headache
patients (10.4%) than in non-headache controls (2.3%; OR 4.60, 95%
CI 1.99–10.68). As previously reported (12), GH/PE occurred more
frequently in patients with migraine (12.6%; OR 5.55, 95% CI 2.34–
13.12 vs controls) than in those with TTH (5.7%; OR 2.73, 95% CI
0.89–8.32 vs controls).
The multivariate analysis showed that the association between
headache, either migraine or tension-type, and adverse perinatal
outcomes remained statistically signiﬁcant after adjusting for
family history of hypertension and occurrence of GH/PE (Tables 2
and 3).
4. Comment
This prospective cohort study shows that pregnant women
suffering from headache have a statistically signiﬁcantly higher
incidence of preterm delivery and a higher, although not
signiﬁcantly, incidence of SGA infants than do non-headache
subjects. Moreover, it was observed that both migraine and TTH
are risk factors for preterm delivery and that headache patients
have a higher, though not statistically signiﬁcant, percentage of
spontaneous preterm labour than do non-headache women. This
ﬁnding is in disagreement with Banhidy et al. [11], who reported
that although severe maternal migraine and its related drug
treatment may increase the occurrence of pre-eclampsia and
severe nausea/vomiting during pregnancy, it is not associated with
unfavourable delivery outcomes, such as preterm birth and/or low
birth weight. However, Banhidy et al.’s study was retrospective and
the size of the two groups differed greatly (713 women with
migraine and 37,438 controls), which may well represent a
selection bias. We have observed that both migraine and TTH are
related to preterm delivery, and, to the best of our knowledge, this
is the ﬁrst study dealing with the effect of TTH on pregnancy
outcomes. As the drugs usually administered to treat TTH and/or
migraine attacks are often different, it is unlikely that the effect of
the two headache types is drug related. It has been hypothesized
that the use of sumatriptan may inﬂuence perinatal outcome [19].OR (95% CI) Adjusteda
OR (95% CI)
Reference Reference
2.82 (1.31–6.07) 2.74 (1.27–5.91)
Reference Reference
1.01 (0.46–2.21) 1.00 (0.46–2.20)
Table 3









OR (95% CI) Adjusteda
OR (95% CI)
n (%) n (%) n (%)
Preterm delivery (<37 weeks)
No 307 (972) 245 (92.8) Reference Reference 94 (91.3) Reference Reference
Yes 9 (2.8) 19 (7.1) 2.65 (1.18–5.95) 2.55 (1.13–5.75) 9 (8.7) 3.27 (1.26–8.47) 3.22 (1.22–8.20)
SGA (<10th centile)
No 304 (96.2) 255 (96.5) Reference Reference 98 (95.1) Reference Reference
Yes 12 (3.8) 9 (3.4) 0.89 (0.37–2.16) 0.89 (0.37–2.15) 5 (4.9) 1.29 (0.44–3.76) 1.25 (0.39–3.58)
SGA, small for gestational age; TTH, tension-type headache.
a Adjusted for family history of hypertension and for occurrence of GH/PE.
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reported the use of triptans at least three times during pregnancy)
and none of these were TTH patients. Indeed most of our cohort
reported paracetamol as the ﬁrst-line drug, as recommended.
Although in patients with migraine mean birth weight was
lower than that in TTH patients, it was observed that TTH patients
had a higher, although not statistically signiﬁcant, incidence of
small for gestational age infants, potentially reﬂecting a restriction
of intrauterine foetal growth. This ﬁnding suggests that the
pathogenic mechanisms of migraine and TTH on pregnancy
outcome may differ. Whilst vascular mechanisms may be
suggested for subjects suffering from migraine, in TTH patients
a key role may be played by psychological conditions, such as
anxiety or depression, which are common features amongst TTH
patients. We did not investigate these aspects, however, and
therefore cannot provide evidence of this association.
Since there were no differences in the mode of delivery between
headache patients and controls, a potential operator-dependent
effect (i.e. anxiety due to clinical conditions) on the rate of preterm
delivery can be excluded. The size of the sample may well be
responsible for not having found differences in pregnancy
outcomes according to subtypes of migraine (with or without
aura, ‘‘probable’’ migraine) or TTH (pure or ‘‘probable’’ TTH).
A secondary analysis revealed that the incidence of GH/PE was
higher in headache patients than in controls. We previously
reported a higher incidence of hypertensive disorders of pregnancy
in patients suffering from migraine [12]. The present study,
however, evinced a very high incidence of GH/PE also in TTH
patients even if it did not reach statistical signiﬁcance. This is a new
ﬁnding that deserves further investigation. Despite the high
incidence of GH/PE in the headache group, multivariate analysis
revealed that both migraine and TTH are risk factors for preterm
delivery independently of the occurrence of those hypertensive
complications of pregnancy.
Acknowledgments
We thank Mrs. Barbara Wade for editorial assistance. This work
was supported by funding from Italian Ministry of University and
Scientiﬁc Research, PRIN protocol no. 2007/N7HA8S.References
[1] Carson AJ, Ringbauer B, MacKenzie L, Warlow C, Sharpe M. Neurological
disease, emotional disorder, and disability: they are related. A study of 300
consecutive new referrals to the neurology outpatient department. J Neurol
Neurosurg Psychiatry 2000;68:202–6.
[2] Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and
burden of migraine in the United States: data from the American Migraine
Study II. Headache 2001;41:646–57.
[3] Dzoljic E, Sipetic S, Vlajinac H, et al. Prevalence of menstrually related migraine
and nonmigraine primary headache in female students of Belgrade University.
Headache 2002;42:185–93.
[4] Melhado E, Maciel Jr JA, Guerriero CAM. Headaches during pregnancy in women
with a prior history of menstrual headache. Arq Neuropsiquiatr 2005;63:934–40.
[5] Melhado E, Maciel Jr JA, Guerriero CAM. Headache during gestation: evaluation
of 1101 women. Can J Neurol Sci 2007;34:187–92.
[6] Marcus DA, Scharff L, Turk DC. Longitudinal prospective study of headache
during pregnancy and postpartum. Headache 1999;39:625–32.
[7] Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and
postpartum: a prospective study. Cephalalgia 2003;23:197–205.
[8] Maggioni F, Alessi C, Maggino T, Zanchin G. Headache during pregnancy.
Cephalalgia 1997;17:765–9.
[9] Facchinetti F, Allais G, D’Amico R, Benedetto C, Volpe A. The relationship
between headache and preeclampsia: a case–control study. Eur J Obstet
Gynaecol Reprod Biol 2005;121:143–8.
[10] Adeney K, Williams M. Migraine headaches and preeclampsia: an epidemio-
logic review. Headache 2006;46:794–803.
[11] Banhidy F, Acs N, Horvath-Puho E, Czeizel AE. Pregnancy complications and
delivery outcomes in pregnant women with severe migraine. Eur J Obstet
Gynaecol Reprod Biol 2006;124:47–52.
[12] Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive
disorders in pregnancy: a prospective cohort study. Cephalalgia 2008;29:286–92.
[13] Chen H-M, Chen S-F, Chen Y-H, Lin H-C. Increased risk of adverse pregnancy
outcomes for women with migraines: a nationwide population-based study.
Cephalalgia 2010;30:433–8.
[14] Headache Classiﬁcation Subcommittee of the International Headache Society.
The international classiﬁcation of headache disorders: 2nd edition. Cephalal-
gia 2004;24(Suppl. 1):9–160.
[15] Parazzini F, Cortinovis I, Bortolus R, Fedele L, Decarli A. Weight at birth by
gestational age in Italy. Hum Reprod 1995;10:1862–3.
[16] American College of Obstetricians and Gynecologists. Diagnosis and manage-
ment of preeclampsia and eclampsia. ACOG practice bulletin. Obstet Gynecol
2002;99:159–67.
[17] Svensson DA, Ekbom K, Larsson B, Waldenlind E. Lifetime prevalence and
characteristics of recurrent primary headaches in a population-based sample
of Swedish twins. Headache 2002;42:754–65.
[18] Lawn EJ, Gravett MG, Nunes TM, Rubens CE, Stanton C, the GAPPS Review
Group. Global report on preterm birth and stillbirth (1 of 7): deﬁnitions,
description of the burden and opportunities to improve data. BMC Pregnancy
Childbirth 2010;10(Suppl. 1):1–22.
[19] Olesen C, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. Pregnancy outcome
following prescription for sumatriptan. Headache 2000;40:20–4.
